GlassScriptPhysician profile
Walter Clark Young
NPI 1770515868
$2,353.83
in general payments reported to CMS, 2019-2025
27 companies · $15.47 in 2025
The $15.47 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $318 · 2021: $588 · 2022: $526 · 2023: $307 · 2024: $31.11 · 2025: $15.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $649.80 | 2019-2022 | |
| Astellas Pharma US INC | $266.67 | 2019-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $240.41 | 2019-2025 | Novasure, Coolseal Generator, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $167.83 | 2021-2023 | Slynd |
| Pfizer INC. | $153.79 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.13 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $136.32 | 2021-2023 | |
| Urovant Sciences INC | $77.38 | 2022 | |
| Therapeuticsmd, INC. | $70.88 | 2019-2022 | |
| Lupin INC. | $44.21 | 2019 | |
| Scynexis, INC. | $40.61 | 2022 | |
| Myovant Sciences INC. | $37.08 | 2021-2022 | |
| Amgen INC. | $35.58 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $35.31 | 2023 | Gemtesa, Myfembree |
| Duchesnay USA Incorporated | $34.64 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $29.27 | 2023 | Nexplanon |
| Coloplast Corp | $26.83 | 2021-2022 | |
| Coopersurgical, INC. | $25.21 | 2019 | |
| Davol INC. | $21.90 | 2020 | |
| Radius Health, INC. | $20.25 | 2020 | |
| Alexion Pharmaceuticals, INC. | $19.00 | 2019 | |
| Merck Sharp & Dohme LLC | $15.98 | 2019 | |
| Daiichi Sankyo INC. | $15.27 | 2021 | |
| Medtronic Vascular, INC. | $13.89 | 2019 | |
| Medtronic, INC. | $13.76 | 2021 | |
| Millicent US INC | $12.79 | 2020 | |
| Agile Therapeutics, INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.